Related Experiment Videos
Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other
N Arber1, F M Konikoff, M Moshkowitz
1Department of Gastroenterology, Tel-Aviv Medical Center, Ichilov Hospital, Israel.
Insights
Patients with chronic hepatitis C show elevated iron levels and ferritin, distinct from hepatitis B and other liver diseases. This increased iron status in hepatitis C does not correlate with liver iron accumulation.
Area of Science:
- Hepatology
- Gastroenterology
- Clinical Biochemistry
Background:
- Chronic liver diseases encompass various etiologies, including viral hepatitis and nonviral conditions.
- Iron metabolism plays a role in liver disease progression and patient outcomes.
- Distinguishing iron status profiles across different chronic liver diseases is crucial for management.
Purpose of the Study:
- To evaluate and compare iron status markers in patients with chronic liver diseases of diverse origins.
- To investigate the relationship between iron status and liver iron accumulation in these patient groups.
- To identify distinct iron metabolism characteristics in chronic hepatitis C compared to other liver diseases.
Main Methods:
- A cohort of 123 patients with chronic liver diseases was categorized into four groups: hepatitis C, hepatitis B, co-infection, and nonviral liver diseases.
- Iron status was assessed by measuring serum iron, iron-binding capacity, transferrin saturation, and serum ferritin.
- Liver biopsy was performed in 87% of patients to confirm diagnosis and assess hepatic iron.
Main Results:
- Patients with chronic hepatitis C exhibited significantly higher serum iron, iron-binding capacity, and ferritin levels compared to hepatitis B and nonviral liver disease groups.
- Despite elevated iron markers, no evidence of hepatic iron accumulation was detected in any patient group.
- No significant differences in standard liver function parameters were observed among the four groups.
Conclusions:
- Chronic hepatitis C is characterized by increased serum iron, iron saturation, and ferritin levels, differentiating it from hepatitis B and other nonhemochromatotic liver diseases.
- Elevated iron status in hepatitis C does not manifest as increased hepatic iron deposition.
- Recognizing these unique iron metabolism features in hepatitis C is vital for accurate diagnosis and effective treatment strategies.
Abstract:
One hundred twenty-three patients with chronic liver diseases of various etiologies were evaluated for their iron status. The patients were divided into four distinct groups: chronic hepatitis C (63), chronic hepatitis B (14), B + C (3) and nonviral chronic liver diseases (43). In 107 patients (87%) the chronic liver disease was confirmed by biopsy. Mean serum iron (+/- SD) levels in the above four groups were: 166 +/- 62, 103 +/- 52, 142 +/- 48, and 115 micrograms/dl; iron-binding capacity was 346 +/- 80, 325 +/- 72, 297 +/- 27, and 374 +/- 75 micrograms/dl, and iron saturation 50 +/- 18, 32 +/- 16, 48 +/- 16, and 28 +/- 10%, respectively. Serum ferritin, increased in all four groups, was highest in HCV; however, no evidence of hepatic iron accumulation could be found in any of the patients. There were no significant differences in liver function parameters measured in the four groups. We conclude that serum iron, iron saturation, and ferritin are increased in patients with hepatitis C in comparison to hepatitis B or other nonviral, nonhemochromatotic liver diseases. The increased iron status in hepatitis C patients is not manifested by increased liver iron. Awareness of these distinct features of chronic hepatitis C is essential in the diagnosis and treatment of chronic liver diseases.